Thermo Fisher Scientific, Inc, GENERAL ELECTRIC, Merck KGaA, Shimadzu Corporation, WATERS are dominating the Global Chromatography Columns Market in 2018

Global Chromatography Columns Market is expected to grow with the substantial CAGR of 6.1% in the forecast period 2019 to 2026. The years considered for study are as mentioned below.

Access Full Report at https://databridgemarketresearch.com/reports/global-chromatography-columns-market

Global chromatography columns market is an upcoming market which includes key players and local players. The market is growing to the favourable market scenario. The market has a prominent growth in upcoming years due to Mandatory guidelines by regulatory authorities for food & drug development.

Thermo Fisher Scientific, Inc. dominated the chromatography columns market and accounts for the highest market share in 2018 which is followed by GENERAL ELECTRIC, Merck KGaA, Shimadzu Corporation, WATERS. The other key players existing in the market Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Biotage, COLE-PARMER INSTRUMENT COMPANY, LLC, Daicel Corporation., Danaher, KNAUER Wissenschaftliche Geräte GmbH, Nouryon, PerkinElmer Inc., Purolite, Repligen Corporation, Sunresin New Materials Co Ltd Xi`, TOSOH, W. R. Grace & Co.-Conn., YMC Europe GmbH among others

Thermo Fisher Scientific, Inc.:

Thermo Fisher Scientific, Inc. headquartered in Massachusetts, U.S. was founded in 2006. The company help their customers to accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. The company is providing life sciences, industrial & applied science, clinical & diagnostics and lab solutions. The market focus products lie under industrial & applied science. The company deals into analytical instruments, life science solutions, specialty diagnostics, laboratory products & services. The market focus products lie under analytical instruments.

It has its global presence through its subsidiaries Dionex (California), Patheon (Netherlands), Affymetrix (California), FEI Company (U.S.), Cole-Parmer (U.S.), and among others.

It has its global networks through direct sales representatives and distributors in Asia-Pacific, Europe, North America, South Africa and Middle East & Africa.

GENERAL ELECTRIC:

GENERAL ELECTRIC headquartered in Massachusetts, U.S. was founded in 1892. T The company focused on combining world-class engineering with software, manufacturing, materials science and data analytics to deliver high value to customers. The company mainly manages their operation in power, renewable energy, aviation, oil & gas, healthcare, transportation, lightings, capital. The market focus category lies under Healthcare. The product categories are  accessories and supplies, advanced visualization, anaesthesia delivery, bone health and metabolic health, computed tomography, contrast media, diagnostic ECG, edison, EP recording, Goldseal - refurbished systems, healthcare IT, hemodynamic recording, interoperability, interventional image guided systems, life sciences, magnetic resonance imaging, mammography, maternal infant care, molecular imaging, nuclear imaging agents, patient monitoring, radiography, fluoroscopy systems, surgical imaging, ultrasound, ventilators

  • In November 2018, GE Healthcare has opened new biotechnology manufacturing center in U.K. The new facility has the potential to expand production in purification biopharmaceuticals, gene therapies and viral vectors. The new manufacturing unit will company to cater demand in Europe and will help to grow its market position in Europe region.

It has its global networks through subsidiaries in Europe, America, Asia-Pacific, Middle East and Africa. its subsidiaries are GE Capital or Financial Services (U.S.), GE Healthcare (U.S.), General Electric Capital Corporation or GECC (U.S.), GE Industrial (U.S.), GE Capital Global Holdings, LLC (U.S.), Baker Hughes (U.S.) and others.

Merck KGaA:

Merck KGaA headquartered in Darmstadt, Germany was founded in 1891. The company is engaged in providing new ways to treat and protect the people and animals from illness around the world. The company is providing analytics and sample preparation, biopharmaceutical manufacturing, industrial microbiology, IVD/OEM materials and reagents, life science research, reagents, chemicals and labware, small molecule pharmaceuticals, water purification. The market focus products lie under biopharmaceutical manufacturing. The company deals into pharmaceuticals, animal health and others business categories. The market focus products lie under pharmaceuticals.

It has its global presence through its subsidiaries Organon International (Netherlands), Merck Sharp & Dohme ltd (U.K), Aptus Health, Inc. (U.S.), Idenix Pharmaceuticals, Inc.(U.S.), Merck Banyu Co Ltd ( Japan) among others.

It has its global networks through direct sales representatives and distributors in Asia-Pacific, Europe, North America, South Africa and Middle East & Africa.